An observational study to assess the efficacy of ambulatory blood pressure monitoring in hypertension management among chronic kidney disease patients
PDF

Keywords

Chronic kidney disease
Ambulatory Blood Pressure Monitoring
Haemodialysis
Hypertension
Twice-weekly haemodialysis

How to Cite

1.
Gupta R, Jayaprakash V, Asokan A, Mathew GG. An observational study to assess the efficacy of ambulatory blood pressure monitoring in hypertension management among chronic kidney disease patients. Rev. Colomb. Nefrol. [Internet]. 2026 Apr. 22 [cited 2026 May 3];13(1). Available from: https://revistanefrologia.org/index.php/rcn/article/view/946

Abstract

Introduction: Chronic kidney disease (CKD) poses a significant global health challenge and is often associated with hypertension (HTN) and cardiovascular diseases (CVD). Ambulatory blood pressure monitoring (ABPM) is a promising approach for precise blood pressure assessment, particularly in patients with chronic kidney disease. This study aimed to evaluate the efficacy of ABPM in managing blood pressure (BP) in patients with end-stage renal disease (ESRD) undergoing haemodialysis.

Objective: This study aimed to compare the effectiveness of ambulatory blood pressure monitoring as an adjunct to routine blood pressure management in achieving optimal blood pressure control among patients on haemodialysis. The secondary objectives included a study of the variation in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) at baseline and at 3 months, along with variations of night-time and daytime blood pressure in haemodialysis patients.

Materials and methods: A comparative prospective study was conducted, enrolling 62 patients with chronic kidney disease undergoing haemodialysis twice weekly. ABPM was added to the routine blood pressure monitoring in the experimental group, whereas only routine blood pressure monitoring was conducted in the control group. Demographic data, pre- and post-haemodialysis blood pressure, ABPM recordings, and laboratory parameters were collected. Data analysis included descriptive statistics, t-tests, and chi-square tests.

Results: The mean ages of participants in the experimental and control groups were 52 ± 16.7 years and 47.9 ± 14.3 years, respectively. The study found that ABPM significantly improved blood pressure control compared with routine monitoring at the end of 3 months. Statistically significant differences were observed in mean systolic blood pressure (140 ± 12.7 vs. 151 ± 17.6, P=0.006), diastolic blood pressure (84 ± 6.2 vs. 89 ± 8.6, P=0.011) and mean arterial pressure (106 ± 7 vs. 110 ± 8.4, P=0.046) between the two groups. 

Conclusion: Our study emphasizes ABPM's vital role in improving blood pressure management in CKD patients on haemodialysis and also in identifying the nuances of blood pressure variation in this vulnerable population.

https://doi.org/10.22265/acnef.13.1.946
PDF

References

Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, et al. US Renal Data System 2018 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(Suppl 1):S1-S8. https://doi.org/10.1053/j.ajkd.2019.01.001

Mills KT, Bundy JD, Kelly TN, Reed JE, Keraney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-450. https://doi.org/10.1161/CIRCULATIONAHA.115.018912

Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-2050. https://doi.org/10.1001/jama.2010.650

Kazancio?lu R. Risk factors for chronic kidney disease: An update. Kidney Int. 2013;3(4):368-371. https://doi.org/10.1038/kisup.2013.79

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Mei K, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol. 2006;17(7):2034-2047. https://doi.org/10.1681/ASN.2005101085

Grossman E. Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care. 2013;36(Suppl 2):S307-S311. https://doi.org/10.2337/dcS13-2039

O’Brien E, Dolan E. Ambulatory blood pressure monitoring for the effective management of antihypertensive drug treatment. Clin Ther. 2016;38(10):2142-2151. https://doi.org/10.1016/j.clinthera.2016.08.006

Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: A review. Am J Med. 2015;128(1):14–20. https://doi.org/10.1016/j.amjmed.2014.07.021

Dadlani A, Madan K, Sawhney JPS. Ambulatory blood pressure monitoring in clinical practice. Indian Heart J. 2019;71(1):91-97. https://doi.org/10.1016/j.ihj.2018.11.015

Green BB, Anderson ML, Cook AJ, Ehrlich K, Hall YN, Hsu C, et al. Clinic, home, and kiosk blood pressure measurements for diagnosing hypertension: A randomized diagnostic study. J Gen Intern Med. 2022;37(12):2948-2956. https://doi.org/10.1007/s11606-022-07400-z

McCallum W, Sarnak MJ. Blood pressure target for the dialysis patient. Semin Dial. 2019;32(1):35-40. https://doi.org/10.1111/sdi.12754

Indhumathi E, Angraje S, Mishra B, Macha J. Is ambulatory blood pressure monitoring required for elderly hemodialysis patients during the interdialytic period? - experience of a tertiary care center in South India. Indian J Nephrol. 2022;32(1):60-66. https://doi.org/10.4103/ijn.IJN_160_20

Munter P, Anderson A, Charleston J, Weir M, Wright JT, Townsend R, et al. Hypertension awareness, treatment, and control in adults with CKD: Results from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2010;55(3):441-451. https://doi.org/10.1053/j.ajkd.2009.09.014

Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368-2374. https://doi.org/10.1056/NEJMra060433

Ruiz-Hurtado G, Gorostidi M, Waeber B, Ruilope LM. Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements? Curr Opin Nephrol Hypertens. 2015;24(6):488-491. https://doi.org/10.1097/MNH.0000000000000162

Huang QF, Yang WY, Asayama K, Zhang ZY, Thijs L, Li Y, et al. Ambulatory blood pressure monitoring to diagnose and manage hypertension. Hypertension. 2021;77(2):254-264. https://doi.org/10.1161/HYPERTENSIONAHA.120.14591

Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: A review of recent advances. Hypertens Res. 2012;35(7):695–701. https://doi.org/10.1038/hr.2012.26

De La Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53(3):466–472. https://doi.org/10.1161/HYPERTENSIONAHA.108.124008

Casagrande M, Favieri F, Langher V, Guarino A, Di Pace E, Germano G, et al. The night side of blood pressure: nocturnal blood pressure dipping and emotional (dys) regulation. Int J Environ Res Public Health. 2020;17(23):8892. https://doi.org/10.3390/ijerph17238892

Cunha C, Pereira S, Fernandes JC, Dias VP. 24-hour ambulatory blood pressure monitoring in chronic kidney disease and its influence on treatment. Port J Nephrol Hypert. 2017;31(1):31-36.

Sarafidis P, Theodorakopoulou MP, Loutradis C, Raptis V, Ferro CJ, Papagianni A, et al. Accuracy of peridialytic, intradialytic, and scheduled interdialytic recordings in detecting elevated ambulatory blood pressure in hemodialysis patients. Am J Kidney Dis. 2021;78(5):630-639. https://doi.org/10.1053/j.ajkd.2021.01.022

Sankaranarayanan N, Santos SF, Peixoto AJ. Blood pressure measurement in dialysis patients. Adv Chronic Kidney Dis. 2004;11(2):134-142. https://doi.org/10.1053/j.arrt.2004.01.005

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.